FY25 Bulk Pharma B-RFP ATTACHMENT 1-Technical Product List Template.xlsx
XLSX spreadsheet 39 KB Posted
- Attached to
- Bulk Pharma Group B
- Solicitation number
- 75A50325R00003
About this file
This is a technical product list template spreadsheet for a bulk pharmaceutical solicitation (75A50325R00003) from HHS/ASPR for the Strategic National Stockpile. The template requires offerors to provide detailed information about their capability to supply six pharmaceutical products over a base year plus four option years: Acyclovir Sodium injection, Doxycycline injection, Levophed (Norepinephrine), Meropenem injection, Sodium Chloride injection bags, and Sterile water for injection.
The template includes sections for offerors to specify their business size, NDC/NSN numbers, unit configurations, monthly delivery schedules, manufacturing locations, TAA/BAA compliance, shelf life, and manufacturer/reseller status for each product. A second tab requires past performance information for at least two similar projects completed within the past three years, including contract numbers, descriptions, dollar values, quantities delivered, and points of contact. Annual quantities vary by product but include significant volumes like 2.5 million units of Doxycycline in the base year and over 1 million bags of Sodium Chloride in later option years.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| FY25 Bulk Pharma B-RFP ATTACHMENT 2-Business Template.xlsx | XLSX spreadsheet | |
| FY25 Bulk Pharma B-RFP ATTACHMENT 4 Reps and Certs.docx | DOCX document | |
| FY25 Bulk Pharma B-RFP ATTACHMENT 5-SBCX Industry Subcontracting Guide.pdf | ||
| 75A50325R00003.pdf | ||
| FY25 Bulk Pharma B-RFP ATTACHMENT 3-Q-A Template.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
TAB 1-DELIVERY SCHEDULE
| 75A50325R00003 - Bulk Pharma Group B | OFFEROR:_________________________________________________ | |||||||||||||||||||||||||||||
| TECHNICAL - PRODUCT LIST | ||||||||||||||||||||||||||||||
| DELIVERY SCHEDULE | ||||||||||||||||||||||||||||||
| BASE YEAR & OPTIONAL QUANTITIES | ||||||||||||||||||||||||||||||
| Enter Company Name for each Section | Provide Business Size (Small/Large) | Product Description - BASE YEAR | Provide your National Drug Code (NDC) number for this product and if available your National Stock Number (NSN) number to meet the prescribed product requirements. | USG's preferred UoM Configuration (i.e. amount of eaches, ampoules, bags, bottles of tablets, and vials in a case) | USG's Individual UoM (EA) | Provide Quantity within a Pack (i.e. box, carton, or pack) | Provide Quantity within a Case (i.e. amount of eaches, ampoules, bags, bottles of tablets, and vials in a case) | USG Year 1 QTY per individual UoM (EA) | PROVIDE VENDOR QTY CAPABILITY - YEAR 1 | PROVIDE VENDOR QTY CAPABILITY-YEAR 2 | PROVIDE VENDOR QTY CAPABILITY-YEAR 3 (EA) | PROVIDE VENDOR QTY CAPABILITY-YEAR 4 (EA) | PROVIDE VENDOR QTY CAPABILITY-YEAR 5 (EA) | What is the shelf life for this product? | Are you a manufacturer or an approved certified reseller? Can you provide proof of certification? | Are your products Trade Agreement Act (TAA) and Buy American Act (BAA) compliant? | What country is this product manufactured in? | Delivery Schedule (enter QTY) | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan |
| Acyclovir Sodium solution for injection, 500mg (50mg/ml) in a 10ml vial | Vial | EA | 27,363 | |||||||||||||||||||||||||||
| Doxycycline Inj, Powder, Lyophilized 100mg/10ml | Vial | EA | 2,587,893 | |||||||||||||||||||||||||||
| Levophed (Norepinephrine) 1mg/ml in 4ml amp | Ampoules | EA | 5,952 | |||||||||||||||||||||||||||
| Meropenem for injection, 1g powder vial | Vial | EA | 168,000 | |||||||||||||||||||||||||||
| Sodium Chloride for inj. 0.9% 250 ml flexi bag | Bag | EA | 542,452 | |||||||||||||||||||||||||||
| Sterile water for injection, preservative free, 10ml solution vial | Vial | EA | 1,961,200 |
| Enter Company Name for each Section | Provide Business Size (Small/Large) | Product Description - OPTION YEAR 1 (Optional Quantities) | Provide your National Drug Code (NDC) number for this product and if available your National Stock Number (NSN) number to meet the prescribed product requirements. | USG's preferred UoM Configuration (i.e. amount of eaches, ampoules, bags, bottles of tablets, and vials in a case) | USG's Individual UoM (EA) | Provide Quantity within a Pack (i.e. box, carton, or pack) | Provide Quantity within a Case (i.e. amount of eaches, ampoules, bags, bottles of tablets, and vials in a case) | USG Year 1 QTY per individual UoM (EA) | PROVIDE VENDOR QTY CAPABILITY - YEAR 1 | PROVIDE VENDOR QTY CAPABILITY-YEAR 2 | PROVIDE VENDOR QTY CAPABILITY-YEAR 3 (EA) | PROVIDE VENDOR QTY CAPABILITY-YEAR 4 (EA) | PROVIDE VENDOR QTY CAPABILITY-YEAR 5 (EA) | What is the shelf life for this product? | Are you a manufacturer or an approved certified reseller? Can you provide proof of certification? | Are your products Trade Agreement Act (TAA) and Buy American Act (BAA) compliant? | What country is this product manufactured in? | Delivery Schedule | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan |
| Acyclovir Sodium solution for injection, 500mg (50mg/ml) in a 10ml vial | Vial | EA | 27,364 | |||||||||||||||||||||||||||
| Doxycycline Inj, Powder, Lyophilized 100mg/10ml | Vial | EA | 1,125,159 | |||||||||||||||||||||||||||
| Levophed (Norepinephrine) 1mg/ml in 4ml amp | Ampoules | EA | 10,000 | |||||||||||||||||||||||||||
| Meropenem for injection, 1g powder vial | Vial | EA | 168,000 | |||||||||||||||||||||||||||
| Sodium Chloride for inj. 0.9% 250 ml flexi bag | Bag | EA | 765,217 | |||||||||||||||||||||||||||
| Sterile water for injection, preservative free, 10ml solution vial | Vial | EA | 354,400 |
| Enter Company Name for each Section | Provide Business Size (Small/Large) | Product Description - OPTION YEAR 2 (Optional Quantities) | Provide your National Drug Code (NDC) number for this product and if available your National Stock Number (NSN) number to meet the prescribed product requirements. | USG's preferred UoM Configuration (i.e. amount of eaches, ampoules, bags, bottles of tablets, and vials in a case) | USG's Individual UoM (EA) | Provide Quantity within a Pack (i.e. box, carton, or pack) | Provide Quantity within a Case (i.e. amount of eaches, ampoules, bags, bottles of tablets, and vials in a case) | USG Year 1 QTY per individual UoM (EA) | PROVIDE VENDOR QTY CAPABILITY - YEAR 1 | PROVIDE VENDOR QTY CAPABILITY-YEAR 2 | PROVIDE VENDOR QTY CAPABILITY-YEAR 3 (EA) | PROVIDE VENDOR QTY CAPABILITY-YEAR 4 (EA) | PROVIDE VENDOR QTY CAPABILITY-YEAR 5 (EA) | What is the shelf life for this product? | Are you a manufacturer or an approved certified reseller? Can you provide proof of certification? | Are your products Trade Agreement Act (TAA) and Buy American Act (BAA) compliant? | What country is this product manufactured in? | Delivery Schedule | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan |
| Acyclovir Sodium solution for injection, 500mg (50mg/ml) in a 10ml vial | Vial | EA | 27,364 | |||||||||||||||||||||||||||
| Doxycycline Inj, Powder, Lyophilized 100mg/10ml | Vial | EA | 536,057 | |||||||||||||||||||||||||||
| Levophed (Norepinephrine) 1mg/ml in 4ml amp | Ampoules | EA | 10,000 | |||||||||||||||||||||||||||
| Meropenem for injection, 1g powder vial | Vial | EA | 168,000 | |||||||||||||||||||||||||||
| Sodium Chloride for inj. 0.9% 250 ml flexi bag | Bag | EA | 246,416 | |||||||||||||||||||||||||||
| Sterile water for injection, preservative free, 10ml solution vial | Vial | EA | 1,103,000 |
| Enter Company Name for each Section | Provide Business Size (Small/Large) | Product Description - OPTION YEAR 3 (Optional Quantities) | Provide your National Drug Code (NDC) number for this product and if available your National Stock Number (NSN) number to meet the prescribed product requirements. | USG's preferred UoM Configuration (i.e. amount of eaches, ampoules, bags, bottles of tablets, and vials in a case) | USG's Individual UoM (EA) | Provide Quantity within a Pack (i.e. box, carton, or pack) | Provide Quantity within a Case (i.e. amount of eaches, ampoules, bags, bottles of tablets, and vials in a case) | USG Year 1 QTY per individual UoM (EA) | PROVIDE VENDOR QTY CAPABILITY - YEAR 1 | PROVIDE VENDOR QTY CAPABILITY-YEAR 2 | PROVIDE VENDOR QTY CAPABILITY-YEAR 3 (EA) | PROVIDE VENDOR QTY CAPABILITY-YEAR 4 (EA) | PROVIDE VENDOR QTY CAPABILITY-YEAR 5 (EA) | What is the shelf life for this product? | Are you a manufacturer or an approved certified reseller? Can you provide proof of certification? | Are your products Trade Agreement Act (TAA) and Buy American Act (BAA) compliant? | What country is this product manufactured in? | Delivery Schedule | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan |
| Acyclovir Sodium solution for injection, 500mg (50mg/ml) in a 10ml vial | Vial | EA | 27,364 | |||||||||||||||||||||||||||
| Doxycycline Inj, Powder, Lyophilized 100mg/10ml | Vial | EA | 536,057 | |||||||||||||||||||||||||||
| Levophed (Norepinephrine) 1mg/ml in 4ml amp | Ampoules | EA | 0 | |||||||||||||||||||||||||||
| Meropenem for injection, 1g powder vial | Vial | EA | 168,000 | |||||||||||||||||||||||||||
| Sodium Chloride for inj. 0.9% 250 ml flexi bag | Bag | EA | 1,281,384 | |||||||||||||||||||||||||||
| Sterile water for injection, preservative free, 10ml solution vial | Vial | EA | 354,400 |
| Enter Company Name for each Section | Provide Business Size (Small/Large) | Product Description - OPTION YEAR 4 (Optional Quantities) | Provide your National Drug Code (NDC) number for this product and if available your National Stock Number (NSN) number to meet the prescribed product requirements. | USG's preferred UoM Configuration (i.e. amount of eaches, ampoules, bags, bottles of tablets, and vials in a case) | USG's Individual UoM (EA) | Provide Quantity within a Pack (i.e. box, carton, or pack) | Provide Quantity within a Case (i.e. amount of eaches, ampoules, bags, bottles of tablets, and vials in a case) | USG Year 1 QTY per individual UoM (EA) | PROVIDE VENDOR QTY CAPABILITY - YEAR 1 | PROVIDE VENDOR QTY CAPABILITY-YEAR 2 | PROVIDE VENDOR QTY CAPABILITY-YEAR 3 (EA) | PROVIDE VENDOR QTY CAPABILITY-YEAR 4 (EA) | PROVIDE VENDOR QTY CAPABILITY-YEAR 5 (EA) | What is the shelf life for this product? | Are you a manufacturer or an approved certified reseller? Can you provide proof of certification? | Are your products Trade Agreement Act (TAA) and Buy American Act (BAA) compliant? | What country is this product manufactured in? | Delivery Schedule | Sept | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug |
| Acyclovir Sodium solution for injection, 500mg (50mg/ml) in a 10ml vial | Vial | EA | 27,364 | |||||||||||||||||||||||||||
| Doxycycline Inj, Powder, Lyophilized 100mg/10ml | Vial | EA | 536,057 | |||||||||||||||||||||||||||
| Levophed (Norepinephrine) 1mg/ml in 4ml amp | Ampoules | EA | 10,000 | |||||||||||||||||||||||||||
| Meropenem for injection, 1g powder vial | Vial | EA | 168,000 | |||||||||||||||||||||||||||
| Sodium Chloride for inj. 0.9% 250 ml flexi bag | Bag | EA | 1,281,384 | |||||||||||||||||||||||||||
| Sterile water for injection, preservative free, 10ml solution vial | Vial | EA | 354,400 |
TAB 2- PAST PERFORMANCE
| TECHNICAL - PAST PERFORMANCE | |||
| Provide Past Performace Details in accordance with Section E. | Project 1 | Project 2 | Project 3 |
The Offeror shall provide a description of at least two (2) projects currently in process or have been performed within the past three (3) years (from the release date of this RFQ) that clearly demonstrates the Offeror’s experience in performing manufacturing projects of similar scope, size, and complexity to the requirements described in the statement of work (SOW).
a) Contract number, customer/agency name and contract title;
b) Brief narrative description of the work performed for each of those contracts, including a description of how the previous work demonstrates the Offeror’s capacity to successfully meet the requirements described in the RFP and a discussion of any problems encountered/corrective actions and significant accomplishments.
c) Dollar value, contract type, period of performance, and the quantity and types of products delivered in the performance of the contract.
d) Demonstrated experience related to subfactors 1-3 under Technical Capability.
e) Provide an appropriate point of contact (POC) for each project referenced. POC information shall include name, title, telephone number, and email address. The Government may contact these individuals for additional information as part of this evaluation.
File details come from the government source that posted it. Updated .